Ulcerative colitis trials recruiting in District of Columbia

All Ulcerative colitis trials nationally

Cities in District of Columbia

Recruiting trials in District of Columbia

• A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
  NCT05076175 · Phase: Phase 2, Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
  NCT03816345 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• Therapeutic Endpoint in Pediatric IBD Conditions
  NCT06065228 · Phase: Not specified · Ages: 6 Years to 21 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
  NCT05230173 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.